Form 4: Director Linda Filler Reports Acquisition of Danaher Corp Phantom Shares

Linda Filler, a director of Danaher Corp, reported the acquisition of phantom shares under the company's Non-Employee Directors Deferred Compensation Plan.

Summary

• On July 26, 2024, Linda Filler, a director of Danaher Corp, acquired 8.707 phantom shares of Danaher common stock.
• The acquisition was made under the terms of the Non-Employee Directors Deferred Compensation Plan.
• The phantom shares were acquired at a price of $273.19 per share, equivalent to the closing price of Danaher's common stock on the transaction date.
• Following the transaction, Filler beneficially owns 8,841.393 phantom shares.
• The phantom shares convert into shares of Danaher common stock on a one-for-one basis upon distribution, and Filler is fully vested in all amounts deferred under the Plan.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment. It simply reports a transaction by a company director. The acquisition of phantom shares can be seen as a positive sign of confidence, but it's a routine transaction.

Positives

• The acquisition of phantom shares by a director signals confidence in the company's future performance.
• The Non-Employee Directors Deferred Compensation Plan aligns director interests with shareholder value.

Future Outlook

The document does not contain specific forward-looking statements regarding Danaher Corp's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their alignment with shareholder interests.

Comparison to Industry Standards

• Director compensation plans, including deferred compensation and phantom stock awards, are common practices among publicly traded companies to incentivize and retain board members.
• Danaher's Non-Employee Directors Deferred Compensation Plan is similar to those offered by companies like Siemens, Roche, and Abbott Laboratories, which also utilize deferred compensation plans to align director interests with long-term shareholder value.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates